Formaldehyde found in Brazilian Blowout products

After receiving complaints from consumers, Oregon's Occupational Safety & Health Division and Canadian regulatory body Health Canada tested and determined products from California-based Brazilian Blowout contain high levels of formaldehyde. Using four different testing methods, Oregon OSHA found product samples to have formaldehyde levels between 4.85% and 10.6%, while Health Canada found samples with 12% formaldehyde. In its Oct. 5 release, Brazilian Blowout - marketer of a hair-smoothing treatment administered by salons - says its own testing shows trace formaldehyde levels of less than 0.002%, which is considered safe and "allows for use of the term 'formaldehyde-free.'" Health Canada received complaints of "burning eyes, nose and throat, breathing difficulties," it says, as well as one report of hair loss from use of Brazilian Blowout products. It issued an advisory Oct. 7 urging stylists to stop using Brazilian Blowout treatments and directing consumers to seek medical attention if they are exhibiting reactions. Brazilian Blowout maintains the level of formaldehyde is 10,000 times less than the 40 parts-per-million concentration limit set by California's Proposition 65. As the firm continues its investigation into the claims, "we are confident that all misinformation and inaccurate data will soon be dispelled," it says. FDA weighs in with a notice on its website Oct. 8, stating it has not received any official adverse event reports on Brazilian Blowout but is working with state and local organizations "to determine whether the products or ingredients would be likely to cause health problems under the intended conditions of use.

More from Archive

FTC Consumer Privacy Policy Driven By ‘Straw Man’ Arguments – Commissioner Holyoak

 

The US FTC’s contention that ‘notice and choice’ has failed as the cornerstone of consumer privacy regulation and must be abandoned in favor of data minimization and other more stringent measures does not adequately account for the complexity of business practices and consumer behavior, FTC commissioner Melissa Holyoak asserted at the NAD’s 2024 Annual Conference.

FTC’s New Commissioner ‘Dismayed’ By Agency Overreach

 

FTC Commissioner Melissa Holyoak says the agency has acted outside the bounds afforded by Congress, citing several areas within consumer protection, including a recent update to the final rule for the Health Breach Notification Rule and the commission’s use of notices of penalty offense to serve as the basis for Section 5 settlements. 

Beauty Brands Not On TikTok Shop ‘Really Missing Out’ – KO-Pack

 

At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”

Final Chance To Have Your Say: Take Our Reader Survey This Week

 
• By 

Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

More from HBW Insight

Azelis Grows Nutraceuticals Offering In Iberia With Solchem

 
• By 

Azelis adds dietary supplement ingredients and a large customer base across Spain to its portfolio with the acquisition of Solchem Nature.

Momentum Of Questions About Self-GRAS Meets Wall Of Exemption From ‘Rigorous Review’

 

HHS Secretary Kennedy ‘s opposition to allowing GRAS without notifications has support but also questions just as strong about whether FDA is authorized to conduct a rulemaking to eliminate the option.

Preamble ‘Poison Pill’ Could Haunt ACNU Switch Rule – House Energy And Commerce Members

 

Reps. Latta, Crenshaw and Miller-Meeks contend language in ACNU final rule preamble would allow a sponsor of an approved application to litigate to halt Rx availability of same formulation and “risk eliminating the very rule on which its product approval was based.”